Pennsylvania HR473 designates May 2026 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania.

Pennsylvania HR473 acknowledges the impact of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, on patients and their families. ALS is a fatal neurodegenerative disease that affects motor neurons, leading to muscle weakness and atrophy. The resolution highlights the lack of a known cause, prevention, or cure for ALS, and aims to increase public awareness. The resolution notes that ALS is more common in men, with approximately 5,000 new cases diagnosed annually, and that patients typically survive two to five years after diagnosis.

Pennsylvania HR473 designates May 2026 as "Amyotrophic Lateral Sclerosis Awareness Month" in Pennsylvania.

Pennsylvania HR473 acknowledges the impact of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, on patients and their families. ALS is a fatal neurodegenerative disease that affects motor neurons, leading to muscle weakness and atrophy. The resolution highlights the lack of a known cause, prevention, or cure for ALS, and aims to increase public awareness. The resolution notes that ALS is more common in men, with approximately 5,000 new cases diagnosed annually, and that patients typically survive two to five years after diagnosis.